BORDONI, Martina
 Distribuzione geografica
Continente #
NA - Nord America 821
AS - Asia 686
EU - Europa 520
SA - Sud America 92
AF - Africa 13
OC - Oceania 2
Totale 2.134
Nazione #
US - Stati Uniti d'America 794
SG - Singapore 317
IT - Italia 167
HK - Hong Kong 108
CN - Cina 103
IE - Irlanda 92
BR - Brasile 72
RU - Federazione Russa 70
VN - Vietnam 61
DE - Germania 57
KR - Corea 38
FI - Finlandia 21
CA - Canada 15
AT - Austria 14
GB - Regno Unito 14
NL - Olanda 13
PL - Polonia 13
FR - Francia 12
IN - India 11
BE - Belgio 10
ES - Italia 9
MX - Messico 9
JP - Giappone 7
SE - Svezia 7
AR - Argentina 6
UA - Ucraina 6
ZA - Sudafrica 6
BD - Bangladesh 5
EC - Ecuador 5
ID - Indonesia 5
IQ - Iraq 4
TR - Turchia 4
KW - Kuwait 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
CI - Costa d'Avorio 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
GR - Grecia 2
IL - Israele 2
MA - Marocco 2
PK - Pakistan 2
RO - Romania 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
HU - Ungheria 1
IM - Isola di Man 1
IR - Iran 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UY - Uruguay 1
Totale 2.134
Città #
Singapore 234
Chandler 130
Hong Kong 108
Dublin 88
Ashburn 87
Perugia 79
Seoul 38
Munich 36
Boardman 35
Santa Clara 35
Ann Arbor 34
Los Angeles 28
San Mateo 28
Moscow 24
Dong Ket 21
Beijing 17
Medford 16
Piscataway 16
Princeton 16
Altamura 15
New York 15
Warsaw 13
Brooklyn 12
Turku 12
Brussels 10
Hanoi 10
Lawrence 10
Wilmington 10
Hefei 9
Ho Chi Minh City 9
Redwood City 9
Dallas 8
Rome 7
Tokyo 7
Vicenza 7
Vienna 7
Helsinki 6
Naples 6
Amsterdam 5
Andover 5
Denver 5
Florence 5
Houston 5
Milan 5
Nuremberg 5
Saint Petersburg 5
San Francisco 5
Stockholm 5
São Paulo 5
Toronto 5
Bologna 4
Chicago 4
Den Haag 4
Frankfurt am Main 4
Mexico City 4
Poplar 4
Seattle 4
The Dalles 4
Ankara 3
Cambridge 3
Chennai 3
Des Moines 3
Hải Dương 3
Lappeenranta 3
Montreal 3
Querétaro 3
Secaucus 3
Shanghai 3
Vancouver 3
Abidjan 2
As Sālimīyah 2
Athens 2
Atlanta 2
Baghdad 2
Can Tho 2
Cape Town 2
Columbus 2
Dearborn 2
Fremont 2
Haiphong 2
Irpin 2
Jacksonville 2
Johannesburg 2
Manchester 2
Menlo Park 2
Mumbai 2
New Delhi 2
Norwalk 2
Quito 2
Redmond 2
Rio de Janeiro 2
Riyadh 2
San Diego 2
San Jose 2
Treviso 2
Vĩnh Tường 2
Zhengzhou 2
Ambato 1
Ambāla 1
Annapolis 1
Totale 1.436
Nome #
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 96
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 93
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation 87
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 87
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 84
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease 79
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 78
GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation 77
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 76
Sa1518 – Mechanism of Acute Liver Decompensation Caused by Obeticholic Acid in Cholestasis is Fxr Dependent 75
Mo2014 – Comparative Effects of Bar502, a Dual Fxr and Gpbar1 Agonist, Obeticholic Acid and Ursodeoxycholic Acid in a Rodent Model of Nash 74
Tu1546 – Gpbar1 is a Modulator of Liver Immunity and Its Agonism Reverses Acetaminophen-Induced Hepatotoxicity by Modulating Recruitment of Liver Macrophages 74
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy 74
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 74
GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against Colitis 73
Analysis of Oral and Gut Microbiota Composition in Children with Dental Caries by NGS Approaches 71
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 66
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 65
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 65
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 64
Combinatorial targeting of GPBAR1 and CYSLTR1 reveals a mechanistic role for bile acids and leukotrienes in drug induced liver injury 62
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 61
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases 60
Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation 60
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 59
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis 57
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis 55
Allo-lithocholic acid, a microbiome derived secondary bile acid, attenuates liver fibrosis 48
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 48
Organoids as ex vivo culture system to investigate infection-host interaction in gastric pre-carcinogenesis 44
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 38
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4−/− Mice 36
Modeling Inflammatory Bowel Disease by Intestinal Organoids 33
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4 −/− mice 20
Totale 2.213
Categoria #
all - tutte 10.929
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.929


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0 0 0 0 0 9 6 3 0 7 2 22
2021/2022129 4 23 1 5 1 1 13 24 2 16 13 26
2022/2023388 27 60 4 32 39 43 0 17 143 1 14 8
2023/2024195 8 17 3 5 12 1 51 26 17 8 26 21
2024/2025646 7 41 29 40 41 60 51 69 133 29 93 53
2025/2026726 93 98 74 202 220 39 0 0 0 0 0 0
Totale 2.213